Sun Pharma's arm to commence distribution of its formulation products in India

09 Apr 2019 Evaluate

Sun Pharmaceutical Industries’ wholly owned subsidiary -- Sun Pharma Distributors will commence distributing its formulation products in India from this month in a phased manner on the same terms as was with Aditya Medisales. This phased transition is expected to be fully completed by the first quarter of 2019-20.

In January, the company had announced that distribution related to the company's India domestic formulations business shall be transitioned from Aditya Medisales to its wholly-owned subsidiary.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharma Inds. Share Price

1779.30 -3.50 (-0.20%)
17-Dec-2025 11:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.30
Dr. Reddys Lab 1276.00
Cipla 1493.60
Zydus Lifesciences 917.00
Lupin 2116.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×